• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 32 of 100
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
HealthAstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
COVID vaccine CDC allergies
HealthWhat to know about the CDC’s new COVID vaccine guidance for people with health conditions
By Sy MukherjeeDecember 27, 2020
Doctors and patients face a painkiller crisis, even as they fight COVID
CommentaryDoctors and patients face a painkiller crisis, even as they fight COVID
By Joseph StaufferDecember 16, 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
CommentaryBig Pharma’s new CEOs must step up to erase inequities in drug access
By Jayasree K. IyerDecember 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
FinanceWhy shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
Coronavirus
HealthThe science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
Protein folding image for Eye on A.I.
NewslettersLessons from DeepMind’s breakthrough in protein-folding A.I.
By Jeremy KahnDecember 1, 2020
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
TechKnow when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
By Jeremy KahnNovember 30, 2020
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
HealthDeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
By Jeremy KahnNovember 30, 2020
A picture of a protein shape.
TechIn a major scientific breakthrough, A.I. predicts the exact shape of proteins
By Jeremy KahnNovember 30, 2020
COVID vaccine FDA timeline
HealthIt may be a matter of weeks, not months, before Americans can start getting COVID vaccines
By Sy MukherjeeNovember 28, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
HealthFor AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
Trump administration and drug prices transparency
HealthNew Trump administration rule directs insurers to reveal what they pay for prescriptions
By Harris Meyer and Kaiser Health NewsNovember 19, 2020
Amazon Pharmacy is live: Shoppers can now order prescriptions directly through the tech giant
TechAmazon Pharmacy is live: Shoppers can now order prescriptions directly through the tech giant
By BloombergNovember 17, 2020
1...
  • 30
  • 31
  • 32
  • 33
  • 34
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
AI
Anthropic disables Fable and Mythos AI models after U.S. government bars it from giving foreigners accessplaceholder alt text
By Jeremy KahnJune 13, 2026
Startups & Venture
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'placeholder alt text
By Emma HinchliffeJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.